Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Impairment of goodwill and intangible assets | NaN | 0 | 58,843 | NaN |
| Gain (loss) on disposition of business | NaN | 4,831 | NaN | NaN |
| Gain on debt extinguishment | NaN | 0 | 0 | 0 |
| Net loss | -4,480 | -8,250 | -72,673 | -22,565 |
| Credit loss expense | 335 | 352 | -51 | 1,833 |
| Depreciation and amortization | 4,418 | 6,205 | 6,473 | 12,566 |
| Gain on disposal or divestiture | NaN | NaN | -319 | 5,150 |
| Amortization of financing costs charged to interest expense | 330 | 328 | 390 | 804 |
| Amortization of right-of-use assets | 322 | 376 | 515 | 1,274 |
| Gain on divestiture | -14,543 | NaN | NaN | NaN |
| Stock-based compensation expense | 4,828 | 5,512 | 6,422 | 16,195 |
| Change in contingent consideration | 0 | 0 | 0 | 102 |
| Loss on investments | -1,285 | NaN | NaN | NaN |
| Other non-cash expense (income), net | -1,764 | -8 | -1,825 | 8,076 |
| Accounts receivable | -18,316 | -5,835 | -4,643 | -10,165 |
| Prepaid expenses and other assets | -154 | -2,033 | -1,395 | 1,625 |
| Accounts payable | -167 | 372 | 1,644 | -1,837 |
| Other accrued expenses | 586 | -2,486 | 842 | 920 |
| Partner share liability | -7,238 | 2,712 | -5,007 | -5,913 |
| Consumer incentive liability | -11,552 | 13 | -3,819 | -4,174 |
| Net cash used in operating activities | -5,642 | 13,010 | 1,761 | -5,481 |
| Acquisition of property and equipment | 28 | 25 | 14 | 441 |
| Capitalized software development costs | 2,276 | 2,532 | 4,450 | 8,320 |
| Proceeds from divestiture of businesses, net of cash divested | NaN | 480 | NaN | NaN |
| Proceeds from divestiture, net of cash divested | -200 | NaN | 0 | 200 |
| Net cash used in investing activities | -2,304 | -2,277 | -4,464 | -8,561 |
| Proceeds from issuance of debt | NaN | 56,000 | NaN | NaN |
| Principal payments of debt | NaN | 62,000 | NaN | NaN |
| Principal payments of 2020 convertible senior notes | NaN | NaN | NaN | 0 |
| Proceeds from termination of capped calls related to convertible notes | NaN | 0 | 0 | 0 |
| Proceeds from issuance of common stock | NaN | 0 | 0 | 0 |
| Equity issuance costs | NaN | NaN | 0 | 0 |
| Proceeds from issuance of debt | -45,000 | NaN | 50,000 | NaN |
| Settlement of contingent consideration | 0 | 0 | 0 | 5,000 |
| Equity issuance costs | NaN | 0 | NaN | NaN |
| Proceeds from issuance of 2024 convertible senior notes | NaN | NaN | NaN | 0 |
| Principal payment of debt | -40,000 | NaN | 50,000 | 0 |
| Debt issuance costs | 22 | 17 | 12 | 93 |
| Net cash used in financing activities | -5,022 | -6,017 | -12 | -5,093 |
| Effect of exchange rates on cash and cash equivalents | -78 | 42 | -69 | 286 |
| Net decrease in cash and cash equivalents | -13,046 | 4,758 | -2,784 | -18,849 |
| Cash and cash equivalents beginning of period | 48,719 | 43,961 | 65,594 | NaN |
| Cash and cash equivalents end of period | 35,673 | 48,719 | 43,961 | NaN |